article thumbnail

Pharma’s spend on AI in drug discovery ‘could top $3bn by 2025’

pharmaphorum

That spend is due to reach of $3 billion by 2025, according to GlobalData analyst Kitty Whitney, who notes that there has been a steady stream of startups formed in the last three to four years to tap into the emerging AI market. The post Pharma’s spend on AI in drug discovery ‘could top $3bn by 2025’ appeared first on.

article thumbnail

Opinion: Policymakers must take action on the physician shortage

STAT

These workforce challenges are compounded by the fact that America — both physicians  and our patient population — is also aging, and the number of available doctors is shrinking. Nearly 334,000  health care professionals left the workforce in 2021.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

First-in-class drug slows tumor growth in preclinical study - set for clinic by 2025

Outsourcing Pharma

A small molecule compound has shown to induce strong anti-tumor immune responses â an area where medical need is high.

article thumbnail

Diving deeper into AI discovery, Sanofi signs 5-drug deal with Atomwise

pharmaphorum

The deal will see Atomwise identify, synthesize, and advance lead compounds for up to five drug targets that will then be exclusively Sanofi’s to develop. A recent report from GlobalData predicted that pharma spending on AI drug discovery would hit $3 billion in 2025.

article thumbnail

Sandoz, Ares extend digital alliance on antimicrobial resistance

pharmaphorum

Sandoz and Ares – a subsidiary of OpGen – started working together in 2018, and with the extension will continue the project until the end of January 2025. “AMR, which is now estimated to directly account for nearly 1.3 The post Sandoz, Ares extend digital alliance on antimicrobial resistance appeared first on.

article thumbnail

2nd Annual Next Generation Pharmaceutical Cleanrooms Conference

pharmaphorum

In 2025, the global cleanroom technology market is expected to reach nearly $5 billion. View the brochure and to download visit [link]. The post 2nd Annual Next Generation Pharmaceutical Cleanrooms Conference appeared first on.

article thumbnail

The osteoarthritis market is expected to increase to $3.8bn in 2031

Pharmaceutical Technology

billion in 2031, at a compound annual growth rate (CAGR) of 4.4%. Two categories of novel therapies stand out: cell therapies and therapies with novel MOAs, with new products in each category being forecast to launch between 2023 and 2025. The osteoarthritis (OA) market was valued at $2.5 of the 7MM sales, respectively.